SpringWorks Inventory from 2010 to 2024

SWTX Stock  USD 41.22  1.83  4.65%   
SpringWorks Therapeutics Inventory yearly trend continues to be fairly stable with very little volatility. Inventory is likely to outpace its year average in 2024. During the period from 2010 to 2024, SpringWorks Therapeutics Inventory regression line of annual values had r-squared of  0.01 and arithmetic mean of  1,198,118. View All Fundamentals
 
Inventory  
First Reported
2000-03-31
Previous Quarter
7.7 M
Current Value
9.8 M
Quarterly Volatility
M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check SpringWorks Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among SpringWorks Therapeutics' main balance sheet or income statement drivers, such as Interest Expense of 923.7 K, Selling General Administrative of 207.4 M or Total Revenue of 5.2 M, as well as many indicators such as Price To Sales Ratio of 444, Dividend Yield of 0.0 or PTB Ratio of 3.86. SpringWorks financial statements analysis is a perfect complement when working with SpringWorks Therapeutics Valuation or Volatility modules.
  
Check out the analysis of SpringWorks Therapeutics Correlation against competitors.
For more information on how to buy SpringWorks Stock please use our How to Invest in SpringWorks Therapeutics guide.

Latest SpringWorks Therapeutics' Inventory Growth Pattern

Below is the plot of the Inventory of SpringWorks Therapeutics over the last few years. It is SpringWorks Therapeutics' Inventory historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in SpringWorks Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Inventory10 Years Trend
Pretty Stable
   Inventory   
       Timeline  

SpringWorks Inventory Regression Statistics

Arithmetic Mean1,198,118
Geometric Mean0.00
Coefficient Of Variation237.80
Mean Deviation1,916,989
Median0.00
Standard Deviation2,849,153
Sample Variance8.1T
Range10.2M
R-Value(0.11)
Mean Square Error8.6T
R-Squared0.01
Significance0.69
Slope(70,488)
Total Sum of Squares113.6T

SpringWorks Inventory History

20244.7 M
20233.1 M
2011null
201010.2 M

Other Fundumenentals of SpringWorks Therapeutics

About SpringWorks Therapeutics Financial Statements

SpringWorks Therapeutics investors use historical fundamental indicators, such as SpringWorks Therapeutics' Inventory, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in SpringWorks Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Inventory3.1 M4.7 M
Change To Inventory-3.1 M-2.9 M
Inventory Turnover 0.12  0.11 
Days Of Inventory On Hand2.4 K2.1 K
Days Of Inventory Outstanding2.4 K2.1 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for SpringWorks Stock Analysis

When running SpringWorks Therapeutics' price analysis, check to measure SpringWorks Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SpringWorks Therapeutics is operating at the current time. Most of SpringWorks Therapeutics' value examination focuses on studying past and present price action to predict the probability of SpringWorks Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SpringWorks Therapeutics' price. Additionally, you may evaluate how the addition of SpringWorks Therapeutics to your portfolios can decrease your overall portfolio volatility.